Exhibit 99.2
JOINT FILING AGREEMENT
The undersigned hereby agree that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the common stock, par value $0.01 per share, of Indaptus Therapeutics, Inc., is filed on behalf of each of the undersigned in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Each of the undersigned further agrees that this Joint Filing Agreement be included as an exhibit to such Schedule 13D. In evidence thereof, the undersigned have caused this Joint Filing Agreement to be executed on their behalf this 30th day of March, 2026.
| Yun Yao | ||
| By: |
/s/ Yun Yao |
|
| Yun Yao | ||
| Date: | 03/30/2026 | |
| Sino Lion Ventures Limited | ||
| By: |
/s/ Chenhao Xu |
|
| Chenhao Xu, Authorized Signatory | ||
| Date: | 03/30/2026 | |
| Junyi Dai | ||
| By: |
/s/ Junyi Dai |
|
| Junyi Dai | ||
| Date: | 03/30/2026 | |
| Ting Yang | ||
| By: |
/s/ Ting Yang |
|
| Ting Yang | ||
| Date: | 03/30/2026 | |
| Lina Deng | ||
| By: |
/s/ Lina Deng |
|
| Lina Deng | ||
| Date: | 03/30/2026 | |
| Chenhao Xu | ||
| By: |
/s/ Chenhao Xu |
|
| Chenhao Xu | ||
| Date: | 03/30/2026 | |